Literature DB >> 17074951

Familiality of obsessive-compulsive disorder in nonclinical and clinical subjects.

Hans Joergen Grabe1, Stephan Ruhrmann, Susan Ettelt, Friederike Buhtz, Andrea Hochrein, Svenja Schulze-Rauschenbach, Klaus Meyer, Susanne Kraft, Claudia Reck, Ralf Pukrop, Harald J Freyberger, Joachim Klosterkötter, Peter Falkai, Ulrich John, Wolfgang Maier, Michael Wagner.   

Abstract

OBJECTIVE: Studies of the familiality of obsessive-compulsive disorder (OCD) have yielded inconsistent results. This study compared the familial aggregation of OCD in first-degree relatives of community subjects with never-treated OCD, outpatients with OCD, and comparison subjects.
METHOD: Fifteen persons from the community with untreated OCD were matched on age and interview type (direct or through family informants) with 90 OCD patients from four treatment facilities and 70 comparison subjects. Direct or indirect interviews using the German-language version of the Schedule for Affective Disorders and Schizophrenia-Lifetime Version for Anxiety Disorders (DSM-IV) were obtained from 58, 285, and 247 first-degree relatives, respectively, of the three groups. The rate of OCD in case versus comparison relatives was assessed with chi-square tests, and odds ratios were calculated for risk estimation. Cox proportional hazards analysis was used to estimate the age-related risk of relatives of being affected by OCD.
RESULTS: Cox proportional hazards analyses revealed a 6.2-fold higher risk (hazard ratio) for relatives of all OCD cases for definite OCD and a 2.2-fold higher risk for subclinical OCD compared with relatives of comparison subjects. For relatives of community subjects with OCD, the risk for definite OCD (10.3% versus 5.6%) was 1.6, and the risk for subclinical OCD (15.4% versus 4.1%) was 3.4 compared with relatives of OCD patients from treatment sites.
CONCLUSIONS: These results from the first controlled European family study of OCD confirm earlier U.S. data on the familiality of OCD in patients recruited from treatment facilities. The finding of a comparable familial aggregation of definite OCD and a higher familial aggregation of subclinical OCD in relatives of never-treated persons with OCD from the community strongly supports the impact of familial-genetic factors in OCD.

Entities:  

Mesh:

Year:  2006        PMID: 17074951     DOI: 10.1176/ajp.2006.163.11.1986

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  21 in total

Review 1.  Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective.

Authors:  David L Pauls; Amitai Abramovitch; Scott L Rauch; Daniel A Geller
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

Review 2.  Genetics of obsessive-compulsive disorder and related disorders.

Authors:  Heidi A Browne; Shannon L Gair; Jeremiah M Scharf; Dorothy E Grice
Journal:  Psychiatr Clin North Am       Date:  2014-07-23

3.  Antisaccade performance in patients with obsessive-compulsive disorder and unaffected relatives: further evidence for impaired response inhibition as a candidate endophenotype.

Authors:  Leonhard Lennertz; Friederike Rampacher; Andrea Vogeley; Svenja Schulze-Rauschenbach; Ralf Pukrop; Stephan Ruhrmann; Joachim Klosterkötter; Wolfgang Maier; Peter Falkai; Michael Wagner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-23       Impact factor: 5.270

4.  The effects of acute serotonin challenge on executive planning in patients with obsessive-compulsive disorder (OCD), their first-degree relatives, and healthy controls.

Authors:  Christine Lochner; Samuel R Chamberlain; Martin Kidd; Lian Taljaard; Naomi A Fineberg; Trevor W Robbins; Dan J Stein
Journal:  Psychopharmacology (Berl)       Date:  2020-07-08       Impact factor: 4.530

Review 5.  Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Authors:  Christopher Pittenger; Michael H Bloch; Kyle Williams
Journal:  Pharmacol Ther       Date:  2011-09-22       Impact factor: 12.310

6.  Reduced prefrontal gyrification in obsessive-compulsive disorder.

Authors:  Thomas Wobrock; Oliver Gruber; Andrew M McIntosh; Susanne Kraft; Anne Klinghardt; Harald Scherk; Wolfgang Reith; Thomas Schneider-Axmann; Stephen M Lawrie; Peter Falkai; Thomas William Moorhead
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-01-29       Impact factor: 5.270

Review 7.  Recent advances in the genetics of obsessive-compulsive disorder.

Authors:  Jack F Samuels
Journal:  Curr Psychiatry Rep       Date:  2009-08       Impact factor: 5.285

8.  Secondary depression in severe anxiety disorders: a population-based cohort study in Denmark.

Authors:  Sandra M Meier; Liselotte Petersen; Manuel Mattheisen; Ole Mors; Preben B Mortensen; Thomas M Laursen
Journal:  Lancet Psychiatry       Date:  2015-05-14       Impact factor: 27.083

Review 9.  The relationship between impulse-control disorders and obsessive-compulsive disorder: a current understanding and future research directions.

Authors:  Marc Nicholas Potenza; Lorrin Michael Koran; Stefano Pallanti
Journal:  Psychiatry Res       Date:  2009-10-06       Impact factor: 3.222

10.  Association between SLC1A1 gene and early-onset OCD in the Han Chinese population: a case-control study.

Authors:  Haisu Wu; Xuemei Wang; Zeping Xiao; Shunying Yu; Liping Zhu; Dongxiang Wang; Kaida Jiang; Zhen Wang; Tianhong Zhang; Drew Fralick
Journal:  J Mol Neurosci       Date:  2013-04-07       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.